pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

6,238 catalysts · 5,811 phase readout · 2,343 8k filing · 426 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 0 catalysts2026-08-05: 0 catalysts2026-08-06: 0 catalysts2026-08-07: 0 catalysts2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 14 catalysts2026-08-11: 16 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 11 catalysts2026-10-29: 20 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: earnings×type: adcom×type: phase readout×clear all
type
  • phase readout5,811
  • 8k filing2,343
  • earnings426
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07629765: Exploring How Osteopathic Manipulative Treatment May Affect Spinal Fluid Flow: An MRI Study

Sponsor: Edward Via Virginia College of Osteopathic Medicine. Phase: NA. Conditions: Osteopathic Manipulative Treatment (OMT) Effects on Cerebrospinal Fluid (CSF) Dynamics

full page →ctgov ↗
›RECRUITINGphase readoutNCT05856565: Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Predictive Factor of Response to Anti-PD-1

Sponsor: Nantes University Hospital. Phase: . Conditions: Metastatic Melanoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT04309565: Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support

Sponsor: Yale University. Phase: NA. Conditions: Opioid Addiction

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07573800: tDCS and the Cardiovascular System in Community-dwelling Elderly.

Sponsor: Riphah International University. Phase: NA. Conditions: Community-dwelling Elderly

full page →ctgov ↗
›RECRUITINGphase readoutNCT06738407: Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections

Sponsor: Westat. Phase: PHASE4. Conditions: Gonorrhea, Chlamydia, Syphilis, Sexually Transmitted Infections (STIs)

full page →ctgov ↗
›RECRUITINGphase readoutNCT04092192: Forceps vs. Snare IVC Filter Removal

Sponsor: University of Chicago. Phase: NA. Conditions: DVT

full page →ctgov ↗
›COMPLETEDphase readoutNCT06813092: Effects of Resistance Exercise Compared to Whole-body Electromyostimulation in Young Female Dentists.

Sponsor: University of Erlangen-Nürnberg Medical School. Phase: NA. Conditions: Osteopenia, Cardiometabolic Conditions

full page →ctgov ↗
›RECRUITINGphase readoutNCT00900471: Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors

Sponsor: Wake Forest University Health Sciences. Phase: . Conditions: Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific

full page →ctgov ↗
›COMPLETEDphase readoutNCT02750371: Effect of Irradiation of the Cavernous Sinus and the Sellar Region on Autobiographical Memory

Sponsor: University Hospital, Bordeaux. Phase: NA. Conditions: Cavernous Sinus Meningioma, Pituitary Adenoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT06430671: Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis

Sponsor: Cellerys AG. Phase: PHASE1. Conditions: Relapsing-remitting Multiple Sclerosis (RRMS)

full page →ctgov ↗
›COMPLETEDphase readoutNCT04349644: Enhancing Social Competence in Adults With Autism

Sponsor: Vanderbilt University Medical Center. Phase: NA. Conditions: Autism Spectrum Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04838444: Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553)

Sponsor: Valneva Austria GmbH. Phase: PHASE3. Conditions: Chikungunya Virus Infection

full page →ctgov ↗
›COMPLETEDphase readoutNCT04113434: Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome

Sponsor: Children's Hospital of Philadelphia. Phase: . Conditions: Acute Respiratory Distress Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT06933134: Prospective Validation of a Pharmacological Biomarker for Low-Dose Rituximab in Rheumatoid Arthritis

Sponsor: University Hospital, Tours. Phase: . Conditions: Rheumatoid Arthritis (RA)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07639164: Stronger Together: Antenatal Depressive Symptoms - Prevalence and Digital Treatment

Sponsor: University of Turku. Phase: NA. Conditions: Depression / Major Depressive Disorder, Antenatal Depression

full page →ctgov ↗
›COMPLETEDphase readoutNCT07591909: The Airway Pressures During Bag-Valve-Mask Ventilation

Sponsor: Akdeniz University Hospital. Phase: NA. Conditions: Emergency Airway Management, Gastric Inflation Risk During Bag-Valve-Mask Ventilation, Breathing Emergency

full page →ctgov ↗
›RECRUITINGphase readoutNCT06886932: Pain Education After Rotator Cuff Surgery

Sponsor: Elif Dilara Durmaz. Phase: . Conditions: Rotator Cuff Tears, Postoperative Pain Management, Shoulder Dysfunction, Kinesiophobia (Fear of Movement), Postoperative Rehabilitation

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07672132: Zinc Supplementation and Inflammation in Older Medical Patients

Sponsor: Herlev Hospital. Phase: NA. Conditions: Older Medical Patients

full page →ctgov ↗
›RECRUITINGphase readoutNCT07703332: Elongation Longitudinal Decoaptation Ostéo-Articulaire Versus Active Isolated Stretching on Median Nerve Mobility and Pain in Patient With Upper Limb Overuse Syndrome

Sponsor: University of Faisalabad. Phase: NA. Conditions: Upper Limb Overuse Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT04584632: The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery

Sponsor: Efemoral Medical, Inc.. Phase: NA. Conditions: Peripheral Arterial Disease, Vascular Diseases, Stenosis, Femoropopliteal Stenosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07510698: Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer

Sponsor: University of Rome Tor Vergata. Phase: NA. Conditions: Breast Cancer, Mastectomy, Prepectoral Breast Reconstruction, ERAS Programmes

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05542563: Mindfulness and ACL Surgery

Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: ACL, ACL Injury

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07540663: MSCS in BURSTDR Patients

Sponsor: Jessa Hospital. Phase: NA. Conditions: FBSS, PSPSII, Neuropathic Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07157787: Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)

Sponsor: Alexion Pharmaceuticals, Inc.. Phase: PHASE2. Conditions: Primary Membranous Nephropathy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07406893: Reduction of Bacterial Seeding in Total Shoulder Arthroplasty

Sponsor: St. Louis University. Phase: NA. Conditions: Joint Arthroplasty, Shoulder, Cutibacterium Acnes, Prosthetic Joint Infection

full page →ctgov ↗
›COMPLETEDphase readoutNCT06670014: Evaluate the Efficacy and Safety of the Digital Therapeutics Repeech for the Post-Stroke Dysarthria.

Sponsor: HAII corp.ltd. Phase: NA. Conditions: Post-stroke Dysarthria

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05294016: Smart Bra for Diagnosing Breast Cancer

Sponsor: Hopital Nord Franche-Comte. Phase: NA. Conditions: Breast Cancer, Medical Device

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05968716: Addressing Unmet Social Needs Among Hospitalized Children

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Social Needs Screening, Caregiver-care Team Relationships, Social Needs Status, Child Health Status, Caregiver Health Status, Utilization, Health Care

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05797233: Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies

Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06965933: Perioperative Use of Erector Spinae Plane Block (ESPB) and Intravenous Lidocaine Infusion in Anesthetic Management of Spinal Surgery in Children

Sponsor: Saint Petersburg State University, Russia. Phase: PHASE4. Conditions: Regional Anesthesia, Lidocaine Infusion

full page →ctgov ↗
›COMPLETEDphase readoutNCT06613633: Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC

Sponsor: Fudan University. Phase: . Conditions: Third-generation TKI, NSCLC (Advanced Non-small Cell Lung Cancer)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07595133: A Multicenter Clinical Study of Romiplostim N01 in the Treatment of Sepsis-related Thrombocytopenia

Sponsor: Shanghai 10th People's Hospital. Phase: PHASE1. Conditions: Sepsis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05634252: Undergraduate Skin Cancer Prevention Trial

Sponsor: University of Utah. Phase: PHASE3. Conditions: Skin Cancer

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07678047: Leveraging Project ECHO for Improved Cervical Cancer Screening in Ethiopia

Sponsor: Albert Einstein College of Medicine. Phase: NA. Conditions: Cervical Carcinoma, Human Papilloma Virus (HPV)

full page →ctgov ↗
›COMPLETEDphase readoutNCT00353158: A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Phase: PHASE1. Conditions: Healthy Volunteers, Fungal Infections, Bacterial Infections

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07598448: A Study of Complement 3 Glomerulopathy (C3G) Patients Treated With Iptacopan Through an Early Access Program in Spain

Sponsor: Novartis Pharmaceuticals. Phase: . Conditions: Complement 3 Glomerulopathy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06527248: Nitrate, Exercise and Vascular Function in Midlife Women

Sponsor: University of Vienna. Phase: NA. Conditions: Healthy, Menopause, Hypertension, Inflammation

full page →ctgov ↗
›COMPLETEDphase readoutNCT07059455: Erector Spınae Plane Block and Transmuscular Quadratus Lumborum Block In Kıdney Transplantatıon

Sponsor: Kocaeli Derince Education and Research Hospital. Phase: NA. Conditions: Kidney Transplant

full page →ctgov ↗
›COMPLETEDphase readoutNCT00055055: Study of Families With Twins or Siblings Discordant for Rheumatic Disorders

Sponsor: National Institute of Environmental Health Sciences (NIEHS). Phase: . Conditions: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies

full page →ctgov ↗
›RECRUITINGphase readoutNCT06284655: The Effect of a Brief Educational Intervention for Adults With ADHD

Sponsor: St. Olavs Hospital. Phase: NA. Conditions: ADHD

full page →ctgov ↗
›COMPLETEDphase readoutNCT05925855: Effect of Phonophoresis on Trigger Points

Sponsor: Batterjee Medical College. Phase: NA. Conditions: Trigger Point Pain, Myofascial

full page →ctgov ↗
›COMPLETEDphase readoutNCT04975555: Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy

Sponsor: University of Alabama at Birmingham. Phase: PHASE2. Conditions: Cytokine Release Syndrome, ICANS, Lymphoma, Non-Hodgkin, Multiple Myeloma, Acute Lymphoblastic Leukemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07633626: Vortioxetine for Cognitive Function in ALK-positive NSCLC Treated With Lorlatinib

Sponsor: Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo. Phase: . Conditions: Advanced ALK/ROS1-positive NSCLC, Carcinoma, Non-Small-Cell Lung (NSCLC), Lung Adenocarcinoma, ALK-positive Non-small Cell Lung Cancer (NSCLC), Cognitive Dysfunction, Depression

full page →ctgov ↗
›COMPLETEDphase readoutNCT07559526: Nutritional Assessment of Patients With Non-small Cell Lung Cancer Treated With Osimertinib

Sponsor: Fundacin Biomedica Galicia Sur. Phase: . Conditions: Non-small-cell Lung Cancer, Sarcopenia, Quality of Life

full page →ctgov ↗
›RECRUITINGphase readoutNCT07359443: Combination of Chemotherapy and Adaptive MR-Guided Radiotherapy to Improve Outcomes in Patients With Esophageal Adenocarcinoma

Sponsor: UMC Utrecht. Phase: PHASE1. Conditions: Esophageal Adenocarcinoma, Esophageal Adenocarcinoma (EAC), Adenocarcinoma - Gastroesophageal Junction (GEJ)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05534243: The ED-AWARENESS-2 Trial

Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Awareness, Mechanical Ventilation, Intubation Complication, PTSD

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07429643: Endoscopic Ultrasound-Guided Loco-regional Chemotherapy Injection as Adjuvant Therapy for Locally Advanced Pancreatic Cancer.

Sponsor: Assiut University. Phase: PHASE2. Conditions: Locally Advanced Pancreatic Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07526415: Effect of Recording Duration on Heart Rate Variability During taVNS

Sponsor: Sinop University. Phase: NA. Conditions: Healthy Volunteers

full page →ctgov ↗
›COMPLETEDphase readoutNCT03848715: Sleep and Healthy Aging Research on Depression for Younger Women

Sponsor: University of California, Los Angeles. Phase: PHASE1. Conditions: Anhedonia, Depression

full page →ctgov ↗
›COMPLETEDphase readoutNCT06422767: Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers

Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Hepatitis B

full page →ctgov ↗
← prev
page 124 of 125
next →